Clinical Trial Update: Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial suggests that injecting cross-linked hyaluronan gel reduces rectal toxicity from radiation therapy in men with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cross-linked Hyaluronan Gel (cross-linked hyaluronic acid gel)

Snippet

Sponsor: Cancer Center of Irvine | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED